Reversible ageusia as an adverse effect of hydroxychloroquine treatment

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 5, 2009, Pages 604-605

  Fleury, O ^a   Droitcourt, C ^a   Polard, E ^b   Chevrant Breton, J ^a  

^a Department of Neurology ^*  (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; MEPACRINE;

ADULT; AGEUSIA; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RASH; REVERSIBLE AGEUSIA; SKIN PIGMENTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; XEROSTOMIA;

ADULT; AGEUSIA; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 63849234570     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02984.x     Document Type: Letter

References (6)

1. Rynes RI. Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 1997 36 : 799 805.
2. Fardet L, Revuz J. Synthetic antimalarials. Ann Dermatol Venereol 2005 132 : 665 674.
3. Weber JC, Alt M, Blaison G, Welsch M, Martin T, Pasquali JL. Changes in taste and smell caused by hydroxychloroquine. Presse Med 1996 25 : 213.
4. Kettaneh A, Fain O, Stirnemann J, Thomas M. Taste disorders. Rev Med Interne 2002 23 : 622 631.
5. Tauveron I, Thieblot P. Regression of propylthiouracil-induced dysgeusia after treatment with zinc. Therapie 1991 46 : 410.
6. Ohkoshi N, Shoji S. Reversible ageusia induced by losartan: a case report. Eur J Neurol 2002 9 : 315.